{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:47:55Z","timestamp":1794937675933,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81322017"],"award-info":[{"award-number":["81322017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771230"],"award-info":[{"award-number":["81771230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1505222"],"award-info":[{"award-number":["U1505222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"publisher","award":["NCET-13-0736"],"award-info":[{"award-number":["NCET-13-0736"]}],"id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2017XQ1072"],"award-info":[{"award-number":["2017XQ1072"]}]},{"name":"National Key Clinical Specialty Discipline Construction Program"},{"name":"Key Clinical Specialty Discipline Construction Program of Fujian"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13024-018-0269-1","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T12:15:03Z","timestamp":1530879303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China"],"prefix":"10.1186","volume":"13","author":[{"given":"En-Lin","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Zhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1449-0114","authenticated-orcid":false,"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"269_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ejhg.2017.124","volume":"25","author":"S Morais","year":"2017","unstructured":"Morais S, Raymond L, Mairey M, Coutinho P, Brand\u00e3o E, Ribeiro P, Loureiro JL, Sequeiros J, Brice A, Alonso I, et al. Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. Eur J Hum Genet. 2017;25:1217\u201328.","journal-title":"Eur J Hum Genet"},{"key":"269_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42:174\u201383.","journal-title":"Neuroepidemiology"},{"key":"269_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","volume":"261","author":"T Lo Giudice","year":"2014","unstructured":"Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A. Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol. 2014;261:518\u201339.","journal-title":"Exp Neurol"},{"key":"269_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","volume":"7","author":"S Salinas","year":"2008","unstructured":"Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7:1127\u201338.","journal-title":"Lancet Neurol"},{"key":"269_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","volume":"16","author":"PV de Souza","year":"2017","unstructured":"de Souza PV, de Rezende Pinto WB, de Rezende Batistella GN, Bortholin T, Oliveira AS. Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum. 2017;16:525\u201351.","journal-title":"Cerebellum"},{"key":"269_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00439-015-1536-7","volume":"134","author":"C Tesson","year":"2015","unstructured":"Tesson C, Koht J, Stevanin G. Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology. Hum Genet. 2015;134:511\u201338.","journal-title":"Hum Genet"},{"key":"269_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/brain\/aww307","volume":"140","author":"A Estrada-Cuzcano","year":"2017","unstructured":"Estrada-Cuzcano A, Martin S, Chamova T, Synofzik M, Timmann D, Holemans T, Andreeva A, Reichbauer J, De Rycke R, Chang DI, et al. Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78). Brain. 2017;140:287\u2013305.","journal-title":"Brain"},{"key":"269_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1600-0404.2008.01074.x","volume":"119","author":"JL Loureiro","year":"2009","unstructured":"Loureiro JL, Miller-Fleming L, Thieleke-Matos C, Magalhaes P, Cruz VT, Coutinho P, Sequeiros J, Silveira I. Novel SPG3A and SPG4 mutations in dominant spastic paraplegia families. Acta Neurol Scand. 2009;119:113\u20138.","journal-title":"Acta Neurol Scand"},{"key":"269_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.24611","volume":"79","author":"R Sch\u00fcle","year":"2016","unstructured":"Sch\u00fcle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, Klimpe S, Gallenm\u00fcller C, Kurzwelly D, Henkel D, et al. Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients. Ann Neurol. 2016;79:646\u201358.","journal-title":"Ann Neurol"},{"key":"269_CR10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/brain\/aww111","volume":"139","author":"E Kara","year":"2016","unstructured":"Kara E, Tucci A, Manzoni C, Lynch DS, Elpidorou M, Bettencourt C, Chelban V, Manole A, Hamed SA, Haridy NA, et al. Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain. 2016;139:1904\u201318.","journal-title":"Brain"},{"key":"269_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink JK. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. 2013;126:307\u201328.","journal-title":"Acta Neuropathol"},{"key":"269_CR12","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/brain\/awv178","volume":"138","author":"JM Solowska","year":"2015","unstructured":"Solowska JM, Baas PW. Hereditary spastic paraplegia SPG4: what is known and not known about the disease. Brain. 2015;138:2471\u201384.","journal-title":"Brain"},{"key":"269_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1:1151\u20135.","journal-title":"Lancet"},{"key":"269_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/ana.10757","volume":"54","author":"CJ McDermott","year":"2003","unstructured":"McDermott CJ, Grierson AJ, Wood JD, Bingley M, Wharton SB, Bushby KM, Shaw PJ. Hereditary spastic paraparesis. Disrupted intracellular transport associated with spastin mutation. Ann Neurol. 2003;54:748\u201359.","journal-title":"Ann Neurol"},{"key":"269_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/15472","volume":"23","author":"J Hazan","year":"1999","unstructured":"Hazan J, Fonknechten N, Mavel D, Paternotte C, Samson D, Artiguenave F, Davoine CS, Cruaud C, Durr A, Wincker P, et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet. 1999;23:296\u2013303.","journal-title":"Nat Genet"},{"key":"269_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/ejhg.2008.147","volume":"17","author":"M Shoukier","year":"2009","unstructured":"Shoukier M, Neesen J, Sauter SM, Argyriou L, Doerwald N, Pantakani DV, Mannan AU. Expansion of mutation spectrum, determination of mutation cluster regions and predictivestructural classification of SPAST mutations in hereditary spastic paraplegia. Eur J Hum Genet. 2009;17:187\u201394.","journal-title":"Eur J Hum Genet"},{"key":"269_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and theAssociation for molecular pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"269_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ng1980","volume":"39","author":"G Stevanin","year":"2007","unstructured":"Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS, Martin E, Ouvrard-Hernandez AM, Tessa A, Bouslam N, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007;39:366\u201372.","journal-title":"Nat Genet"},{"key":"269_CR19","doi-asserted-by":"crossref","unstructured":"Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, Wilkinson PA, Madrid RE, Patel H, Hentati F, et al. Sequence Alterations within CYP7B1 Implicate Defective Cholesterol Homeostasis in Motor-Neuron Degeneration. Am J Hum Genet. 2008;82:510\u20135.","DOI":"10.1016\/j.ajhg.2007.10.001"},{"key":"269_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MPG.0b013e31815a9911","volume":"46","author":"I Ueki","year":"2008","unstructured":"Ueki I, Kimura A, Nishiyori A, Chen HL, Takei H, Nittono H, Kurosawa T. Neonatal cholestatic liver disease in an Asian patient with a homozygous mutation in the oxysterol 7alpha-hydroxylase gene. J Pediatr Gastroenterol Nutr. 2008;46:465\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"269_CR21","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1093\/hmg\/ddt644","volume":"23","author":"S Havlicek","year":"2014","unstructured":"Havlicek S, Kohl Z, Mishra HK, Prots I, Eberhardt E, Denguir N, Wend H, Pl\u00f6tz S, Boyer L, Marchetto MC, et al. Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients\u2019 neurons. Hum Mol Genet. 2014;23:2527\u201341.","journal-title":"Hum Mol Genet"},{"key":"269_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev.genet.38.072902.093019","volume":"39","author":"K Okamoto","year":"2005","unstructured":"Okamoto K, Shaw JM. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Annu Rev Genet. 2005;39:503\u201336.","journal-title":"Annu Rev Genet"},{"key":"269_CR23","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.2174\/0929867324666170616105200","volume":"24","author":"V Shoshan-Barmatz","year":"2017","unstructured":"Shoshan-Barmatz V, Krelin Y, Chen Q. VDAC1 as a player in mitochondria-mediated apoptosis and target for modulating apoptosis. Curr Med Chem. 2017;24:4435\u201346.","journal-title":"Curr Med Chem"},{"key":"269_CR24","first-page":"1228","volume":"2016","author":"T Arif","year":"1857","unstructured":"Arif T, Krelin Y, Shoshan-Barmatz V. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation. Biochim Biophys Acta. 1857;2016:1228\u201342.","journal-title":"Biochim Biophys Acta"},{"key":"269_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41418-017-0020-4","volume":"25","author":"NMC Connolly","year":"2018","unstructured":"Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bola\u00f1os JP, Culmsee C, Dawson VL, Deshmukh M, Duchen MR, et al. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ. 2018;25:542\u201372.","journal-title":"Cell Death Differ"},{"key":"269_CR26","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1172\/JCI77598","volume":"124","author":"J Chang","year":"2014","unstructured":"Chang J, Lee S, Blackstone C. Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation. J Clin Invest. 2014;124:5249\u201362.","journal-title":"J Clin Invest"},{"key":"269_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1\u2013222.","journal-title":"Autophagy"},{"key":"269_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/archneur.59.2.281","volume":"59","author":"IA Meijer","year":"2002","unstructured":"Meijer IA, Hand CK, Cossette P, Figlewicz DA, Rouleau GA. Spectrum of SPG4 mutations in a large collection of north American families with hereditary spastic paraplegia. Arch Neurol. 2002;59:281\u20136.","journal-title":"Arch Neurol"},{"key":"269_CR29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.pediatrneurol.2007.02.003","volume":"36","author":"MA Blair","year":"2007","unstructured":"Blair MA, Riddle ME, Wells JF, Breviu BA, Hedera P. Infantile onset of hereditary spastic paraplegia poorly predicts the genotype. Pediatr Neurol. 2007;36:382\u20136.","journal-title":"Pediatr Neurol"},{"key":"269_CR30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00415-011-5934-z","volume":"258","author":"A Orlacchio","year":"2011","unstructured":"Orlacchio A, Montieri P, Babalini C, Gaudiello F, Bernardi G, Kawarai T. Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation. J Neurol. 2011;258:1361\u20133.","journal-title":"J Neurol"},{"key":"269_CR31","doi-asserted-by":"publisher","first-page":"E376","DOI":"10.1002\/humu.20920","volume":"30","author":"C Goizet","year":"2009","unstructured":"Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat. 2009;30:E376\u201385.","journal-title":"Hum Mutat"},{"key":"269_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jns.2014.05.063","volume":"343","author":"M Muglia","year":"2014","unstructured":"Muglia M, Citrigno L, D'Errico E, Magariello A, Distaso E, Gasparro AA, Scarafino A, Patitucci A, Conforti FL, Mazzei R, et al. A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness. J Neurol Sci. 2014;343:218\u201320.","journal-title":"J Neurol Sci"},{"key":"269_CR33","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1212\/01.wnl.0000244413.49258.f5","volume":"67","author":"C Beetz","year":"2006","unstructured":"Beetz C, Nygren AO, Schickel J, Auer-Grumbach M, Burk K, Heide G, Kassubek J, Klimpe S, Klopstock T, Kreuz F, et al. High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology. 2006;67:1926\u201330.","journal-title":"Neurology"},{"key":"269_CR34","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1086\/320111","volume":"68","author":"IK Svenson","year":"2001","unstructured":"Svenson IK, Ashley-Koch AE, Gaskell PC, Riney TJ, Cumming WJ, Kingston HM, Hogan EL, Boustany RM, Vance JM, Nance MA, et al. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet. 2001;68:1077\u201385.","journal-title":"Am J Hum Genet"},{"key":"269_CR35","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1523\/JNEUROSCI.3159-07.2008","volume":"28","author":"JM Solowska","year":"2008","unstructured":"Solowska JM, Morfini G, Falnikar A, Himes BT, Brady ST, Huang D, Baas PW. Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia. J Neurosci. 2008;28:2147\u201357.","journal-title":"J Neurosci"},{"issue":"4","key":"269_CR36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.neuron.2017.04.042","volume":"94","author":"E Tortosa","year":"2017","unstructured":"Tortosa E, Adolfs Y, Fukata M, Pasterkamp RJ, Kapitein LC, Hoogenraad CC. Dynamic Palmitoylation targets MAP6 to the axon to promote microtubule stabilization during neuronal polarization. Neuron. 2017;94(4):809\u201325.","journal-title":"Neuron"},{"key":"269_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tcb.2005.08.004","volume":"15","author":"PW Baas","year":"2005","unstructured":"Baas PW, Karabay A, Qiang L. Microtubules cut and run. Trends Cell Biol. 2005;15:518\u201324.","journal-title":"Trends Cell Biol"},{"key":"269_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1600-0854.2006.00403.x","volume":"7","author":"FJ Ahmad","year":"2006","unstructured":"Ahmad FJ, He Y, Myers KA, Hasaka TP, Francis F, Black MM, Baas PW. Effects of dynactin disruption and dynein depletion on axonal microtubules. Traffic. 2006;7:524\u201337.","journal-title":"Traffic"},{"key":"269_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1750-1326-7-29","volume":"7","author":"C Fang","year":"2012","unstructured":"Fang C, Bourdette D, Banker G. Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases. Mol Neurodegener. 2012;7:29.","journal-title":"Mol Neurodegener"},{"key":"269_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1242\/dmm.010884","volume":"6","author":"G Abrahamsen","year":"2013","unstructured":"Abrahamsen G, Fan Y, Matigian N, Wali G, Bellette B, Sutharsan R, Raju J, Wood SA, Veivers D, Sue CM, et al. A patient-derived stem cell model of hereditary spastic paraplegia with SPASTmutations. Dis Model Mech. 2013;6:489\u2013502.","journal-title":"Dis Model Mech"},{"key":"269_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/stem.1569","volume":"32","author":"KR Denton","year":"2014","unstructured":"Denton KR, Lei L, Grenier J, Rodionov V, Blackstone C, Li XJ. Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells. 2014;32:414\u201323.","journal-title":"Stem Cells"},{"key":"269_CR42","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/jnen\/62.11.1166","volume":"62","author":"SB Wharton","year":"2003","unstructured":"Wharton SB, McDermott CJ, Grierson AJ, Wood JD, Gelsthorpe C, Ince PG, Shaw PJ. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol. 2003;62:1166\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"key":"269_CR43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1468-1331.2008.02247.x","volume":"15","author":"C Paisan-Ruiz","year":"2008","unstructured":"Paisan-Ruiz C, Nath P, Wood NW, Singleton A, Houlden H. Clinical heterogeneity and genotype-phenotype correlations in hereditary spastic paraplegia because of Spatacsin mutations (SPG11). Eur J Neurol. 2008;15:1065\u201370.","journal-title":"Eur J Neurol"},{"issue":"5","key":"269_CR44","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1212\/01.wnl.0000319646.23052.d1","volume":"71","author":"L Samaranch","year":"2008","unstructured":"Samaranch L, Riverol M, Masdeu JC, Lorenzo E, Vidal-Taboada JM, Irigoyen J, Pastor MA, de Castro P, Pastor P. SPG11 compound mutations in spastic paraparesis with thin corpus callosum. Neurology. 2008;71(5):332\u20136.","journal-title":"Neurology"},{"key":"269_CR45","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ejhg.2015.240","volume":"24","author":"K Choquet","year":"2016","unstructured":"Choquet K, Tetreault M, Yang S, La Piana R, Dicaire MJ, Vanstone MR, Mathieu J, Bouchard JP, Rioux MF, Rouleau GA, et al. SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases. Eur J Hum Genet. 2016;24:1016\u201321.","journal-title":"Eur J Hum Genet"},{"key":"269_CR46","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1093\/brain\/aws240","volume":"135","author":"S Klebe","year":"2012","unstructured":"Klebe S, Depienne C, Gerber S, Challe G, Anheim M, Charles P, Fedirko E, Lejeune E, Cottineau J, Brusco A, et al. Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy. Brain. 2012;135:2980\u201393.","journal-title":"Brain"},{"key":"269_CR47","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/brain\/awp073","volume":"132","author":"C Goizet","year":"2009","unstructured":"Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M, Forlani S, Guyant-Mar\u00e9chal L, Fontaine B, et al. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain. 2009;132:1589\u2013600.","journal-title":"Brain"},{"key":"269_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10048-008-0158-9","volume":"10","author":"S R","year":"2009","unstructured":"R S, Brandt E, Karle KN, Tsaousidou M, Klebe S, Klimpe S, Auer-Grumbach M, Crosby AH, H\u00fcbner CA, Sch\u00f6ls L, et al. Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia. Neurogenetics. 2009;10:97\u2013104.","journal-title":"Neurogenetics"},{"key":"269_CR49","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/brain\/awm293","volume":"131","author":"G Stevanin","year":"2008","unstructured":"Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, Rosa AL, Lerer I, Hamri A, Alegria P, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131:772\u201384.","journal-title":"Brain"},{"key":"269_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/acn3.64","volume":"1","author":"B Renvoise","year":"2014","unstructured":"Renvoise B, Chang J, Singh R, Yonekawa S, FitzGibbon EJ, Mankodi A, Vanderver A, Schindler A, Toro C, Gahl WA, et al. Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11. Ann Clin Transl Neurol. 2014;1:379\u201389.","journal-title":"Ann Clin Transl Neurol"},{"key":"269_CR51","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/brain\/awt227","volume":"136","author":"C Vantaggiato","year":"2013","unstructured":"Vantaggiato C, Crimella C, Airoldi G, Polishchuk R, Bonato S, Brighina E, Scarlato M, Musumeci O, Toscano A, Martinuzzi A, et al. Defective autophagy in spastizin mutated patients with hereditary spastic paraparesis type 15. Brain. 2013;136:3119\u201339.","journal-title":"Brain"},{"key":"269_CR52","doi-asserted-by":"publisher","unstructured":"Mishra HK, Prots I, Havlicek S, Kohl Z, Perez-Branguli F, Boerstler T, Anneser L, Minakaki G, Wend H, Hampl M, et al. GSK3\u00df-dependent dysregulation of neurodevelopment in SPG11-patient iPSC model. Ann Neurol. 2016; https:\/\/doi.org\/10.1002\/%20ana.24633.","DOI":"10.1002\/%20ana.24633."},{"key":"269_CR53","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1093\/hmg\/ddu200","volume":"23","author":"F P\u00e9rez-Brangul\u00ed","year":"2014","unstructured":"P\u00e9rez-Brangul\u00ed F, Mishra HK, Prots I, Havlicek S, Kohl Z, Saul D, Rummel C, Dorca-Arevalo J, Regensburger M, Graef D, et al. Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia. Hum Mol Genet. 2014;23:4859\u201374.","journal-title":"Hum Mol Genet"},{"key":"269_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005454","volume":"11","author":"RE Varga","year":"2015","unstructured":"Varga RE, Khundadze M, Damme M, Nietzsche S, Hoffmann B, Stauber T, Koch N, Hennings JC, Franzka P, Huebner AK, et al. In vivo evidence for lysosome depletion and impaired Autophagic clearance in hereditary spastic paraplegia type SPG11. PLoS Genet. 2015;11:e1005454.","journal-title":"PLoS Genet"},{"key":"269_CR55","doi-asserted-by":"publisher","unstructured":"Walker C, El-Khamisy SF. Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia. Brain. 2018; https:\/\/doi.org\/10.1093\/brain\/awy076 .","DOI":"10.1093\/brain\/awy076"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-018-0269-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T01:42:58Z","timestamp":1661564578000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-018-0269-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1186\/s13024-018-0269-1","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed written consents were obtained from all the participants. This study was approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University (FYYY2006\u201301\u201319-01).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"36"}}